Neogen Reports Q1 Fiscal 2027 Earnings with Revenue Growth and Raised Full-Year Guidance
Neogen Corporation (NEOG) reported first-quarter fiscal year 2027 results, showing revenue of $222.8 million, a 6.5% increase driven by growth in both the Food Safety and Animal Safety segments. Core revenue grew at an 8.1% rate when excluding timing-related benefits from customer orders and distributor inventory adjustments. The company raised its full-year guidance for FY27 to $885–$890 million, up from a previous range of $880–$885 million. Adjusted EBITDA was reported at $41.6 million with an 18.7% margin and free cash flow improved by $18 million year over year to $4.7 million. Neogen also expects proceeds of $140 million from the divestiture of its Genomics business, which it plans to use for debt reduction. Management highlighted strong international revenue performance with double-digit growth in Asia Pacific and noted ongoing challenges such as elevated input costs affecting farmers and a multiquarter manufacturing transfer that must be carefully managed.
Tickers: $NEOG
Topics: adjusted_ebitda debt_reduction free_cash_flow guidance_update revenue_growth